19:50 IST
BSE
Other Announcement
Mankind Pharma Other Announcement
Mankind Pharma has been assigned an ESG rating of 68.21 ('Leader' category) by Niche99 ESG Ratings, based on publicly available data for FY 2025-26.
Mankind Pharma Ltd
- Share price
- ₹2,500.00
- Market cap
- ₹1,03,261 Cr
- Revenue (annual)
- ₹14,278 Cr
- Net profit (annual)
- ₹1,913 Cr
- P/E (TTM)
- 50.5×Sector 47.4×
- Promoter holding
- 72.63%-0.03% QoQ
- FII holding
- 9.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 8Annual General Meeting 4Other Announcement 3Management Change 2Employee Stock Options 2Earnings Call 2Share Pledge 1Results Update 1Partnership 1Financial Results 1Debt & Borrowing 1Business Update 1Board Meeting Date 1
Time
3 announcements with these filters
13:58 IST
BSE
Other Announcement
Mankind Pharma Other Announcement
Mankind Pharma has received an improved ESG rating of 64 from CRISIL, categorized as 'Strong'. The rating was assigned independently without company engagement.
16:21 IST
BSE
Other Announcement
Mankind Pharma Other Announcement
Mankind Pharma Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) with the exchange. This is a standard periodic disclosure of the company's ownership structure.